Gilman Hill Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Gilman Hill Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Buy	+1,125	New	+$193K	0.03%	224
2024 Q1	–	Sell	-1,625	Closed	-$221K	–	219
2023 Q4	$221K	Buy	+1,625	New	+$198K	0.04%	191
2023 Q3	–	Sell	-1,941	Closed	-$246K	–	213
2023 Q2	$246K	Buy	1,941 +316	+19%	+$41K	0.05%	183
2023 Q1	$210K	Hold	1,625	–	–	0.04%	191
2022 Q4	$213K	Buy	+1,625	New	+$210K	0.04%	202

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

CMH Wealth Management Portsmouth, New Hampshire $655M AUM 25.75% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return